Date: December 7, 2022
Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET)
Join Tom Fletcher, Scientific Director, Research and Development, and Guy Matthews, Director of Single Use technologies solutions as they discuss our latest advances in Manufacturing Science and Technology (MSAT) Services and single-use technology solutions.
Discover the innovative technologies FUJIFILM Irvine Scientific has developed to create targeted and efficient solutions for cell culture media, and buffer preparation for biopharmaceutical manufacturers.
The MSAT Service focuses on developing user-friendly cell culture media for late-stage development and manufacturing of biologic drug substances for cell and gene therapies. As priorities shift from process performance to improving efficiencies and reducing risks The MSAT Service can optimize workflow and production time while ensuring consistency and reliability.
Preview the future of hydration for cell culture media buffers, the Oceo Rover, a single-use alternative to current stirred tank mixing technologies. The Oceo Rover is designed specifically for the hydration of powdered media buffers in a closed system, a fully automated programmable platform.
Learn more about unlocking your bioprocessing operational potential with FUJIFILM Irvine Scientific.
Learning Objectives
- Discover the ways simplifying media preparation can reduce risk in bio pharmaceutical manufacturing
- Discuss the advantages of automation and single-use technologies for bioprocessing operations
- Examine the importance of consistency and productivity of your media prep and hydration workflows
- Identify ways in which media and hydration preparation methods can help to improve cell culture media and reduce manufacturing costs
Webinars will be available for unlimited on-demand viewing after live event.
Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.